183 related articles for article (PubMed ID: 31806376)
1. FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.
Isono Y; Furuya M; Kuwahara T; Sano D; Suzuki K; Jikuya R; Mitome T; Otake S; Kawahara T; Ito Y; Muraoka K; Nakaigawa N; Kimura Y; Baba M; Nagahama K; Takahata H; Saito I; Schmidt LS; Linehan WM; Kodama T; Yao M; Oridate N; Hasumi H
Biochem Biophys Res Commun; 2020 Feb; 522(4):931-938. PubMed ID: 31806376
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue.
Wada S; Neinast M; Jang C; Ibrahim YH; Lee G; Babu A; Li J; Hoshino A; Rowe GC; Rhee J; Martina JA; Puertollano R; Blenis J; Morley M; Baur JA; Seale P; Arany Z
Genes Dev; 2016 Nov; 30(22):2551-2564. PubMed ID: 27913603
[TBL] [Abstract][Full Text] [Related]
3. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.
Hong SB; Oh H; Valera VA; Baba M; Schmidt LS; Linehan WM
PLoS One; 2010 Dec; 5(12):e15793. PubMed ID: 21209915
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.
Hasumi H; Baba M; Hasumi Y; Huang Y; Oh H; Hughes RM; Klein ME; Takikita S; Nagashima K; Schmidt LS; Linehan WM
J Natl Cancer Inst; 2012 Nov; 104(22):1750-64. PubMed ID: 23150719
[TBL] [Abstract][Full Text] [Related]
6. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Schmidt LS
Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
[TBL] [Abstract][Full Text] [Related]
7. BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.
Hasumi H; Furuya M; Tatsuno K; Yamamoto S; Baba M; Hasumi Y; Isono Y; Suzuki K; Jikuya R; Otake S; Muraoka K; Osaka K; Hayashi N; Makiyama K; Miyoshi Y; Kondo K; Nakaigawa N; Kawahara T; Izumi K; Teranishi J; Yumura Y; Uemura H; Nagashima Y; Metwalli AR; Schmidt LS; Aburatani H; Linehan WM; Yao M
Hum Mol Genet; 2018 Aug; 27(15):2712-2724. PubMed ID: 29767721
[TBL] [Abstract][Full Text] [Related]
8. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M
Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225
[TBL] [Abstract][Full Text] [Related]
9. Birt-Hogg-Dube syndrome: clinicopathological features of the lung.
Furuya M; Nakatani Y
J Clin Pathol; 2013 Mar; 66(3):178-86. PubMed ID: 23223565
[TBL] [Abstract][Full Text] [Related]
10. FLCN: The causative gene for Birt-Hogg-Dubé syndrome.
Schmidt LS; Linehan WM
Gene; 2018 Jan; 640():28-42. PubMed ID: 28970150
[TBL] [Abstract][Full Text] [Related]
11. Loss of FLCN inhibits canonical WNT signaling via TFE3.
Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP
Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and immunohistochemical study of 9 families.
Furuya M; Tanaka R; Koga S; Yatabe Y; Gotoda H; Takagi S; Hsu YH; Fujii T; Okada A; Kuroda N; Moritani S; Mizuno H; Nagashima Y; Nagahama K; Hiroshima K; Yoshino I; Nomura F; Aoki I; Nakatani Y
Am J Surg Pathol; 2012 Apr; 36(4):589-600. PubMed ID: 22441547
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.
Yan M; Gingras MC; Dunlop EA; Nouët Y; Dupuy F; Jalali Z; Possik E; Coull BJ; Kharitidi D; Dydensborg AB; Faubert B; Kamps M; Sabourin S; Preston RS; Davies DM; Roughead T; Chotard L; van Steensel MA; Jones R; Tee AR; Pause A
J Clin Invest; 2014 Jun; 124(6):2640-50. PubMed ID: 24762438
[TBL] [Abstract][Full Text] [Related]
14. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome.
Kennedy JC; Khabibullin D; Boku Y; Shi W; Henske EP
Semin Respir Crit Care Med; 2020 Apr; 41(2):247-255. PubMed ID: 32279295
[TBL] [Abstract][Full Text] [Related]
15. Folliculin impairs breast tumor growth by repressing TFE3-dependent induction of the Warburg effect and angiogenesis.
El-Houjeiri L; Biondini M; Paquette M; Kuasne H; Pacis A; Park M; Siegel PM; Pause A
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779410
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.
Schmidt LS; Linehan WM
Nat Rev Urol; 2015 Oct; 12(10):558-69. PubMed ID: 26334087
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
Schmidt LS; Linehan WM
Expert Opin Orphan Drugs; 2015; 3(1):15-29. PubMed ID: 26581862
[TBL] [Abstract][Full Text] [Related]
18. FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation.
Dunlop EA; Seifan S; Claessens T; Behrends C; Kamps MA; Rozycka E; Kemp AJ; Nookala RK; Blenis J; Coull BJ; Murray JT; van Steensel MA; Wilkinson S; Tee AR
Autophagy; 2014 Oct; 10(10):1749-60. PubMed ID: 25126726
[TBL] [Abstract][Full Text] [Related]
19. TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
Di Malta C; Zampelli A; Granieri L; Vilardo C; De Cegli R; Cinque L; Nusco E; Pece S; Tosoni D; Sanguedolce F; Sorrentino NC; Merino MJ; Nielsen D; Srinivasan R; Ball MW; Ricketts CJ; Vocke CD; Lang M; Karim B; Lanfrancone L; Schmidt LS; Linehan WM; Ballabio A
EMBO Mol Med; 2023 May; 15(5):e16877. PubMed ID: 36987696
[TBL] [Abstract][Full Text] [Related]
20. Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation.
Baba M; Endoh M; Ma W; Toyama H; Hirayama A; Nishikawa K; Takubo K; Hano H; Hasumi H; Umemoto T; Hashimoto M; Irie N; Esumi C; Kataoka M; Nakagata N; Soga T; Yao M; Kamba T; Minami T; Ishii M; Suda T
J Bone Miner Res; 2018 Oct; 33(10):1785-1798. PubMed ID: 29893999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]